By Nono Hu, Senior Manager, Branding & Messaging, LSN
Life Science Nation (LSN) is proud to release the RESI 2014 fall video, which captures the happenings and buzz from the third Redefining Early Stage Investments (RESI) Conference at Fenway Park. LSN is pleased that RESI provided scientist-entrepreneurs and investors with an opportunity to have a compelling dialogue that will lead to relationships and hopefully future capital allocations.
LSN would like to say thank you for coming to RESI, and we hope to see you at our next conference on January 13, 2015, in San Francisco.
Developing therapeutics differs in many ways from developing medical devices. Therapeutics tend to have longer paths to commercialization and are more capital intensive, but they also usually deliver larger exit payouts. Interestingly, more investors are currently looking for opportunities in both of these sectors than in only one of them. An analysis of approximately 600 investment mandates gathered by our research team over the past year shows the percentage of investors interested in only medical devices, only therapeutics, or both. (See Figure 1.)...
As LSN prepares to bring the next Redefining Early Stage Investments Conference to San Francisco, we are proud to announce that emerging biotech and medical device companies are now invited to apply to showcase their technologies at the event. Over the course of the next two months, thirty innovative companies will be selected from the pool of applications for a highly sought-after presentation space during the week of the 33rd annual JP Morgan Healthcare Conference...